New cocktail approach targets hard-to-treat pancreatic cancer
NCT ID NCT04753879
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests a low-dose combination of five chemotherapy drugs (gemcitabine, nab-paclitaxel, capecitabine, cisplatin, irinotecan) followed by two maintenance drugs (olaparib and pembrolizumab) in 38 people with untreated metastatic pancreatic cancer. The goal is to see if this approach can slow cancer growth and control the disease longer than current treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Gemcitabine, nab-paclitaxel, capecitabine, cisplatin, irinotecan, olaparib, pembrolizumab
- What this could lead to
- If successful, this could offer a new treatment option that delays cancer progression in people with metastatic pancreatic cancer.
- What could go wrong
- This is a small, early-phase trial (38 people) with no control group. The combination has significant side effects, and it may not improve survival or be better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21231, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can three common drugs boost chemotherapy against pancreatic cancer?
- Can an immunotherapy cocktail slow pancreatic cancer? a new trial aims to find out.
- Smart drug delivers chemo directly to pancreatic cancer cells
- Engineered T-Cells take aim at Hard-to-Treat pancreatic cancer
- Gene-Guided chemo cocktail aims to tame tough pancreatic cancer
- New blood test could spot hidden cancer cells that spread